Cover Image
市場調查報告書

MediPoint:末稍血管介入 - 全球市場的分析與預測

MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 361012
出版日期 內容資訊 英文 157 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:末稍血管介入 - 全球市場的分析與預測 MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts
出版日期: 2016年03月14日 內容資訊: 英文 157 Pages
簡介

全球末稍血管介入市場,可望今後急速成長。特別是藥物釋放型球囊 (DEB) 和生物可吸收支架 (BAS),PTFE (聚四氯乙烯) 支架輩受汪目。

本報告提供全球末稍血管介入設備──下肢支架,經皮血管成形術 (PTA) 球囊等──之最新技術·市場趨勢,及今後的市場成長預測相關分析,提供您整體產業結構,及到目前為止的技術開發成果,今後的技術開發與普及可能性,主要的推動及阻礙市場要素,今後的市場趨勢預測,各市場區隔·各地區的詳細趨勢,主要企業·產品簡介等的相關調查。

第1章 目錄

第2章 簡介

第3章 市場進入

  • 全球各地的醫療費給付的趨勢
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
  • 企業合併·收購 (M&A)/主要企業聯盟 (夥伴關係)

第4章 未滿足需求與市場機會

  • 特定症狀藥物釋放型球囊 (DEB) 用的高品質資料
  • 盡量減少頸動脈介入時的圍手術期心臟衰竭風險
    • 抗血栓塗料
    • 伴隨血流逆流的潛血
    • 綜合性的防止栓塞手段
  • 附馬達藥物輸送系統
  • 降低再侵襲率
    • 藥物輸送機制的控制
    • 改善血管內手術方面的醫生訓練

第5章 競爭分析

  • 市場佔有率分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
  • 主要企業·產品簡介
    • Abbott Vascular
    • Biotronik
    • Boston Scientific
    • C.R. Bard
    • Cook Medical
    • Cordis (Cardinal Health)
    • Medtronic
    • Terumo Corporation
    • W.L. Gore
    • 其他的企業
  • 開發中產品分析

第6章 市場未來展望

  • 治療的趨勢
    • 治療範例
    • 下肢的血管再生
    • 頸動脈支架置入術
    • 腎臟動脈支架置入術
  • 市場促進·阻礙因素
    • 推動因素:患病人數的增加
    • 推動因素:血管內手術的實施率的上升
    • 推動因素:改進了股淺動脈血管重建解決方案
    • 推動因素:低調輸送系統發展
    • 推動因素:第二世代支架的登場,降低支架的破損率
    • 阻礙因素:目前醫療費給付方案的影響
    • 阻礙因素:缺乏生物吸收性·末梢血管支架相關之嚴格的臨床實驗結果
  • 各市場區隔的未來展望
    • 全球市場概況
    • 下肢支架
    • 經皮血管成形術 (PTA) 球囊
    • 頸動脈支架
    • 腎臟動脈支架
  • 各地區的未來展望
    • 全球市場概況
    • 北美
    • 歐洲
    • 亞太地區
    • 南美

第7章 附錄

圖表一覽

目錄
Product Code: GDME0223MAR

The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. The rising prevalence of peripheral artery disease (PAD) combined with the increasing endovascular procedure rate will ensure that the market will continue to expand in the coming years. Recent technological advancements within this space, including drug-eluting stents and balloons, bioabsorbable stents (BAS), and polytetrafluoroethylene (PTFE)-covered stents have the potential to revolutionize the future of PAD treatment, as these devices provide improved solutions for complex pathologies.

The technologies covered in this report include lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents. This report focuses on the global peripheral vascular interventions market in North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea), and South America (Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different technologies.

Highlights

Key Questions Answered

  • What is the current and future peripheral vascular interventions market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
  • What are the unmet needs with the current generation of devices? How will emerging technologies fulfill these unmet needs?
  • What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for peripheral vascular interventions?
  • What are the challenges that have hindered widespread adoption of newer technologies?
  • With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global peripheral vascular interventions market?

Scope

  • Overview of recent key industry events and analysis of their market impact.
  • Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2022.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
  • Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
  • Analysis of the current and future market competition in the global peripheral vascular interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Market Access

  • 3.1. Reimbursement Trends
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia-Pacific
    • 3.1.4. South America
  • 3.2. Mergers and Acquisitions/Key Partnerships

4. Unmet Needs and Market Opportunity Analysis

  • 4.1. High Quality Data for Drug-eluting Balloons in Specific Indications
  • 4.2. Minimizing Periprocedural Stroke Risk During Carotid Artery Interventions
    • 4.2.1. Anti-thrombotic Coatings
    • 4.2.2. Occlusion with Flow Reversal
    • 4.2.3. Integrated Embolic Protection
  • 4.3. Motorized Delivery Systems
  • 4.4. Reducing Reintervention Rates
    • 4.4.1. Controlled Drug Delivery Mechanisms
    • 4.4.2. Improving Physician Training in Endovascular Techniques

5. Competitive Assessment

  • 5.1. Market Share Analysis
    • 5.1.1. North America
    • 5.1.2. Europe
    • 5.1.3. Asia-Pacific
    • 5.1.4. South America
  • 5.2. Key Companies and Product Profiles
    • 5.2.1. Abbott Vascular
    • 5.2.2. Biotronik
    • 5.2.3. Boston Scientific
    • 5.2.4. C.R. Bard
    • 5.2.5. Cook Medical
    • 5.2.6. Cordis (Cardinal Health)
    • 5.2.7. Medtronic
    • 5.2.8. Terumo
    • 5.2.9. W.L. Gore
    • 5.2.10. Other Players
  • 5.3. Pipeline Products Assessment

6. Market Outlook

  • 6.1. Procedure Trends
    • 6.1.1. Treatment Paradigm
    • 6.1.2. Lower Extremity Revascularization
    • 6.1.3. Carotid Artery Stenting
    • 6.1.4. Renal Artery Stenting
  • 6.2. Global Market Drivers and Barriers
    • 6.2.1. Driver: Rising Disease Prevalence
    • 6.2.2. Driver: Rising Endovascular Procedure Rates
    • 6.2.3. Driver: Improved Solutions for Superficial Femoral Artery Revascularization
    • 6.2.4. Driver: Development of Low-profile Delivery Systems
    • 6.2.5. Driver: Reduced Stent Fracture Rates with Second Generation Stents
    • 6.2.6. Barrier: Impact of Current Reimbursement Schemes
    • 6.2.7. Barrier: Lack of Rigorous Clinical Trials for Peripheral Bioabsorbable Stents
  • 6.3. Market Outlooks by Segment
    • 6.3.1. Global Overview
    • 6.3.2. Lower Extremity Stents
    • 6.3.3. Percutaneous Transluminal Angioplasty Balloons
    • 6.3.4. Carotid Stents
    • 6.3.5. Renal Stents
  • 6.4. Market Outlooks by Geography
    • 6.4.1. Global Overview
    • 6.4.2. North America
    • 6.4.3. Europe
    • 6.4.4. Asia-Pacific
    • 6.4.5. South America

7. Appendix

  • 7.1. Bibliography
  • 7.2. Abbreviations
  • 7.3. Methodology
    • 7.3.1. Overview
    • 7.3.2. Coverage
    • 7.3.3. Secondary Research
  • 7.4. Forecasting Methodology
  • 7.5. Physicians and Specialists Included in This Study
    • 7.5.1. Key Opinion Leaders
  • 7.6. Primary Research Summary
  • 7.7. About the Authors
    • 7.7.1. Analysts
    • 7.7.2. Global Head of Medical Devices
    • 7.7.3. About GlobalData
  • 7.8. Disclaimer

List of Tables

  • Table 1: Medicare National Average of Inpatient Hospital Reimbursement for Peripheral Vascular Interventions, 2015-2016
  • Table 2: Hospital Outpatient Reimbursement for Peripheral Vascular Interventions, 2015
  • Table 3: Key Mergers, Acquisitions, and Partnerships in Peripheral Vascular Interventions Market
  • Table 4: Abbott Vascular - Company SWOT Analysis
  • Table 5: Abbott Vascular - Marketed Products Assessment
  • Table 6: Abbott Vascular - Clinical Trials to Watch
  • Table 7: Biotronik - Company SWOT Analysis
  • Table 8: Biotronik - Marketed Products Assessment
  • Table 9: Biotronik - Clinical Trials to Watch
  • Table 10: Boston Scientific - Company SWOT Analysis
  • Table 11: Boston Scientific - Marketed Products Assessment
  • Table 12: Boston Scientific - Clinical Trials to Watch
  • Table 13: C.R. Bard - Company SWOT Analysis
  • Table 14: C.R. Bard - Marketed Products Assessment
  • Table 15: C.R. Bard - Clinical Trials to Watch
  • Table 16: Cook Medical - Company SWOT Analysis
  • Table 17: Cook Medical - Marketed Products Assessment
  • Table 18: Cook Medical - Clinical Trials to Watch
  • Table 19: Cordis (Cardinal Health) - Company SWOT Analysis
  • Table 20: Cordis (Cardinal Health) - Marketed Products Assessment
  • Table 21: Cordis (Cardinal Health) - Clinical Trials to Watch
  • Table 22: Medtronic - Company SWOT Analysis
  • Table 23: Medtronic - Marketed Products Assessment
  • Table 24: Medtronic - Clinical Trials to Watch
  • Table 25: Terumo - Company SWOT Analysis
  • Table 26: Terumo - Marketed Products Assessment
  • Table 27: Terumo - Clinical Trials to Watch
  • Table 28: W.L. Gore - Company SWOT Analysis
  • Table 29: W.L. Gore - Marketed Products Assessment
  • Table 30: W.L. Gore - Clinical Trials to Watch
  • Table 31: Other Players Assessment
  • Table 32: Other Clinical Trials to Watch
  • Table 33: Pipeline Products Assessment
  • Table 34: Global Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Table 35: Global Lower Extremity Stents Market Forecast ($m), 2012-2022
  • Table 36: Global PTA Balloons Market Forecast ($m), 2012-2022
  • Table 37: Global Carotid Stents Market Forecast ($m), 2012-2022
  • Table 38: Global Renal Stents Market Forecast ($m), 2012-2022
  • Table 39: Global Peripheral Vascular Interventions Market Forecast ($m), by Country, 2012-2022
  • Table 40: North America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Table 41: Europe Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Table 42: Asia-Pacific Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Table 43: South America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022

List of Figures

  • Figure 1: North America Market Shares for Lower Extremity Stents, by Company, 2015
  • Figure 2: North America Market Shares for Standard PTA Balloons, by Company, 2015
  • Figure 3: North America Market Shares for PTA DEB, by Company, 2015
  • Figure 4: North America Market Shares for Carotid Stents, by Company, 2015
  • Figure 5: Europe Market Shares for Lower Extremity Stents, by Company, 2015
  • Figure 6: Europe Market Shares for Standard PTA Balloons, by Company, 2015
  • Figure 7: Europe Market Shares for PTA DEB, by Company, 2015
  • Figure 8: Europe Market Shares for Carotid Stents, by Company, 2015
  • Figure 9: APAC Market Shares for Lower Extremity Stents, by Company, 2015
  • Figure 10: APAC Market Shares for Standard PTA Balloons, by Company, 2015
  • Figure 11: APAC Market Shares for Standard PTA DEB, by Company, 2015
  • Figure 12: APAC Market Shares for Carotid Stents, by Company, 2015
  • Figure 13: South America Market Shares for Lower Extremity Stents, by Company, 2015
  • Figure 14: South America Market Shares for PTA Balloons, by Company, 2015
  • Figure 15: South America Market Shares for PTA DEB, by Company, 2015
  • Figure 16: South America Market Shares for Carotid Stents, by Company, 2015
  • Figure 17: Treatment Modalities - PAD
  • Figure 18: Global Procedure Volume Forecast for Stenting in the Lower Extremity, by Artery, 2012-2022
  • Figure 19: Global Procedure Volume Forecast for Standard Balloon Angioplasty in the Lower Extremity, by Artery, 2012-2022
  • Figure 20: Global Procedure Volume Forecast for DEB Angioplasty in the Lower Extremity, by Artery, 2012-2022
  • Figure 21: Endovascular Treatment Patterns in the Iliac Arteries, by Region, 2015
  • Figure 22: Endovascular Treatment Patterns in the Femoropopliteal Arteries, by Region, 2015
  • Figure 23: Endovascular Treatment Patterns in the Infrapopliteal Arteries, by Region, 2015
  • Figure 24: Global Procedure Volume Forecast for Carotid Artery Stenting, 2012-2022
  • Figure 25: Global Procedure Volume Forecast for Renal Artery Stenting, 2012-2022
  • Figure 26: Global Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Figure 27: Global Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022
  • Figure 28: Global Lower Extremity Stents Market Forecast ($m), 2012-2022
  • Figure 29: Lower Extremity Stents Market Comparison, by Segment, 2015 and 2022
  • Figure 30: Global PTA Balloons Market Forecast ($m), 2012-2022
  • Figure 31: Global Carotid Stents Market Forecast ($m), 2012-2022
  • Figure 32: Global Renal Stents Market Forecast ($m), 2012-2022
  • Figure 33: Global Peripheral Vascular Interventions Market Forecast ($m), by Country, 2012-2022
  • Figure 34: Global Peripheral Vascular Interventions Market Comparison, by Country, 2015 and 2022
  • Figure 35: North America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Figure 36: North America Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022
  • Figure 37: Europe Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Figure 38: Europe Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022
  • Figure 39: APAC Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Figure 40: APAC Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022
  • Figure 41: South America Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
  • Figure 42: South America Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022
  • Figure 43: Peripheral Vascular Survey Primary Research Participants, by Country
Back to Top